New Research Study Points to Potential of Oleandrin as Therapeutic Strategy for Treatment of HTLV-1, Which Affects Between 10 Million to 15 Million Worldwide

BusinessWire

Originally Posted: October 29, 2019

A 2019 research publication from Robert Harrod (Department of Biological Sciences) was cited on Businesswire. This work was the product of a collaboration with investigators at the UT-Houston M.D. Anderson Cancer Center. The paper was published in the Journal of Antivirals & Antiretrovirals:

Hutchison T., Yapindi L., Malu A., Newman R.A., Sastry K.J., & Harrod R (2019). The botanical glycoside oleandrin inhibits human T-cell leukemia virus type-1 infectivity and Env-dependent virological synapse formation. J. Antivirals & Antiretrovirals 11(2), 1-11.

https://www.businesswire.com/news/home/20191029005927/en/New-Research-Study-Points-Potential-Oleandrin-Therapeutic

By | 2019-10-31T08:52:22-08:00 October 31st, 2019|Biology, Dedman College of Humanities and Sciences, Dedman College Research, Faculty News|Comments Off on New Research Study Points to Potential of Oleandrin as Therapeutic Strategy for Treatment of HTLV-1, Which Affects Between 10 Million to 15 Million Worldwide